Bio-Rad Laboratories Return on Investment 2010-2024 | BIO
Bio-Rad Laboratories ROI - Return on Investment Historical Data | |||
---|---|---|---|
Date | TTM Net Income | LT Investments & Debt | Return on Investment |
2024-06-30 | $0.33B | $7.98B | 3.51% |
2024-03-31 | $0.32B | $10.25B | 3.25% |
2023-12-31 | $0.34B | $9.94B | 3.37% |
2023-09-30 | $0.36B | $9.62B | 3.53% |
2023-06-30 | $0.37B | $9.65B | 3.56% |
2023-03-31 | $0.40B | $10.96B | 3.84% |
2022-12-31 | $0.48B | $10.81B | 4.60% |
2022-09-30 | $0.48B | $9.65B | 4.30% |
2022-06-30 | $0.54B | $10.12B | 4.31% |
2022-03-31 | $0.55B | $11.38B | 4.20% |
2021-12-31 | $0.50B | $13.70B | 3.91% |
2021-09-30 | $0.57B | $15.34B | 4.80% |
2021-06-30 | $0.52B | $11.61B | 5.10% |
2021-03-31 | $0.45B | $10.62B | 4.89% |
2020-12-31 | $0.42B | $9.89B | 5.21% |
2020-09-30 | $0.30B | $8.84B | 4.17% |
2020-06-30 | $0.24B | $7.37B | 3.87% |
2020-03-31 | $0.25B | $6.31B | 4.18% |
2019-12-31 | $0.23B | $5.77B | 4.06% |
2019-09-30 | $-0.06B | $5.57B | -1.07% |
2019-06-30 | $-0.08B | $5.92B | -1.48% |
2019-03-31 | $-0.09B | $5.30B | -1.78% |
2018-12-31 | $-0.10B | $4.46B | -2.08% |
2018-09-30 | $0.18B | $5.34B | 3.85% |
2018-06-30 | $0.18B | $5.08B | 4.40% |
2018-03-31 | $0.14B | $4.92B | 3.70% |
2017-12-31 | $0.12B | $3.37B | 3.65% |
2017-09-30 | $0.04B | $3.28B | 1.32% |
2017-06-30 | $0.03B | $3.25B | 0.99% |
2017-03-31 | $0.06B | $3.14B | 1.82% |
2016-12-31 | $0.06B | $3.01B | 1.84% |
2016-09-30 | $0.14B | $3.14B | 4.50% |
2016-06-30 | $0.14B | $3.05B | 4.77% |
2016-03-31 | $0.16B | $2.98B | 5.47% |
2015-12-31 | $0.17B | $2.92B | 5.92% |
2015-09-30 | $0.16B | $2.87B | 5.79% |
2015-06-30 | $0.16B | $2.80B | 5.93% |
2015-03-31 | $0.16B | $2.63B | 6.22% |
2014-12-31 | $0.15B | $2.62B | 5.67% |
2014-09-30 | $0.15B | $2.61B | 5.70% |
2014-06-30 | $0.15B | $2.69B | 5.58% |
2014-03-31 | $0.15B | $2.67B | 5.78% |
2013-12-31 | $0.17B | $2.62B | 6.29% |
2013-09-30 | $0.19B | $2.56B | 6.91% |
2013-06-30 | $0.23B | $2.80B | 8.19% |
2013-03-31 | $0.25B | $2.76B | 9.10% |
2012-12-31 | $0.26B | $2.75B | 9.99% |
2012-09-30 | $0.29B | $2.67B | 11.22% |
2012-06-30 | $0.30B | $2.59B | 11.81% |
2012-03-31 | $0.29B | $2.57B | 11.76% |
2011-12-31 | $0.31B | $2.48B | 12.57% |
2011-09-30 | $0.29B | $2.43B | 12.09% |
2011-06-30 | $0.29B | $2.46B | 12.47% |
2011-03-31 | $0.29B | $2.35B | 13.07% |
2010-12-31 | $0.28B | $2.27B | 13.35% |
2010-09-30 | $0.26B | $2.16B | 12.69% |
2010-06-30 | $0.25B | $2.04B | 12.61% |
2010-03-31 | $0.24B | $2.04B | 12.27% |
2009-12-31 | $0.23B | $2.02B | 12.51% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $9.247B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $195.617B | 25.27 |
Stryker (SYK) | United States | $137.290B | 32.08 |
Boston Scientific (BSX) | United States | $122.743B | 37.38 |
Medtronic (MDT) | Ireland | $114.552B | 17.05 |
EssilorLuxottica (ESLOY) | France | $108.842B | 0.00 |
Haleon (HLN) | United Kingdom | $48.651B | 35.57 |
Lonza Group Ag (LZAGY) | Switzerland | $46.030B | 0.00 |
ResMed (RMD) | United States | $35.117B | 30.92 |
Koninklijke Philips (PHG) | Netherlands | $30.774B | 23.39 |
Terumo (TRUMY) | Japan | $28.517B | 40.27 |
Zimmer Biomet Holdings (ZBH) | United States | $22.039B | 13.87 |
Baxter (BAX) | United States | $19.851B | 13.46 |
Insulet (PODD) | United States | $16.269B | 68.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.605B | 0.00 |
Demant (WILYY) | Denmark | $8.667B | 0.00 |
BellRing Brands (BRBR) | United States | $7.898B | 33.39 |
Lantheus Holdings (LNTH) | United States | $7.454B | 17.89 |
ICU Medical (ICUI) | United States | $4.261B | 40.67 |
Haemonetics (HAE) | United States | $4.084B | 20.20 |
TG Therapeutics (TGTX) | United States | $3.689B | 39.07 |
Neogen (NEOG) | United States | $3.599B | 37.75 |
Prestige Consumer Healthcare (PBH) | United States | $3.534B | 17.61 |
GN Store Nord (GNNDY) | Denmark | $3.509B | 21.14 |
Perrigo (PRGO) | Ireland | $3.499B | 11.06 |
Envista Holdings (NVST) | United States | $3.398B | 18.13 |
QuidelOrtho (QDEL) | United States | $3.063B | 19.30 |
Agios Pharmaceuticals (AGIO) | United States | $2.595B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.226B | 37.36 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.124B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $2.061B | 54.92 |
Warby Parker (WRBY) | United States | $1.614B | 0.00 |
AdaptHealth (AHCO) | United States | $1.497B | 10.81 |
InMode (INMD) | Israel | $1.464B | 9.32 |
AtriCure (ATRC) | United States | $1.372B | 0.00 |
Owens & Minor (OMI) | United States | $1.247B | 9.63 |
Verano Holdings (VRNOF) | United States | $1.184B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.123B | 0.00 |
Evolus (EOLS) | United States | $1.006B | 0.00 |
PetIQ (PETQ) | United States | $0.919B | 23.30 |
Phibro Animal Health (PAHC) | United States | $0.894B | 18.55 |
National Vision Holdings (EYE) | United States | $0.867B | 27.55 |
Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
Surmodics (SRDX) | United States | $0.549B | 116.64 |
Quanterix (QTRX) | United States | $0.489B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.488B | 14.72 |
Jin Medical (ZJYL) | China | $0.439B | 0.00 |
ZimVie (ZIMV) | United States | $0.435B | 40.41 |
Valneva SE (VALN) | France | $0.432B | 0.00 |
Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.389B | 0.00 |
Cerus (CERS) | United States | $0.324B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.324B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.320B | 8.25 |
Aurora Cannabis (ACB) | Canada | $0.319B | 0.00 |
Biote (BTMD) | United States | $0.307B | 14.18 |
Viemed Healthcare (VMD) | United States | $0.283B | 30.38 |
Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
Zynex (ZYXI) | United States | $0.257B | 45.00 |
Utah Medical Products (UTMD) | United States | $0.232B | 15.41 |
Omeros (OMER) | United States | $0.227B | 0.00 |
MacroGenics (MGNX) | United States | $0.200B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.194B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 67.33 |
FitLife Brands (FTLF) | United States | $0.153B | 20.64 |
Brainsway (BWAY) | Israel | $0.135B | 161.40 |
TriSalus Life Sciences (TLSI) | United States | $0.130B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.121B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.114B | 0.00 |
Veru (VERU) | United States | $0.113B | 0.00 |
Fonar (FONR) | United States | $0.111B | 11.44 |
Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
InterCure (INCR) | Israel | $0.087B | 14.62 |
Zevia PBC (ZVIA) | United States | $0.083B | 0.00 |
Cytosorbents (CTSO) | United States | $0.082B | 0.00 |
Modular Medical (MODD) | United States | $0.074B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.071B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Exagen (XGN) | United States | $0.055B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.051B | 3.35 |
Apyx Medical (APYX) | United States | $0.042B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
Agape ATP (ATPC) | $0.007B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 21.30 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |